COVID-19 vaccines for high risk and immunocompromised patients
The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat...
Saved in:
| Published in | Methods in microbiology Vol. 50; pp. 269 - 279 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat more effectively, as many people as possible need to be vaccinated, especially for high-risk groups having co-morbid conditions such as diabetes, obesity and old age, and possibly those with various forms of immunodeficiencies, such as HIV/AIDS. This chapter focuses primarily on some of the basic biomedical aspects on vaccine design and use, and any possible concerns that need to be considered in getting people in the high-risk category vaccinated and monitored thereafter for their continuous health and well-being. |
|---|---|
| AbstractList | The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat more effectively, as many people as possible need to be vaccinated, especially for high-risk groups having co-morbid conditions such as diabetes, obesity and old age, and possibly those with various forms of immunodeficiencies, such as HIV/AIDS. This chapter focuses primarily on some of the basic biomedical aspects on vaccine design and use, and any possible concerns that need to be considered in getting people in the high-risk category vaccinated and monitored thereafter for their continuous health and well-being. The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat more effectively, as many people as possible need to be vaccinated, especially for high-risk groups having co-morbid conditions such as diabetes, obesity and old age, and possibly those with various forms of immunodeficiencies, such as HIV/AIDS. This chapter focuses primarily on some of the basic biomedical aspects on vaccine design and use, and any possible concerns that need to be considered in getting people in the high-risk category vaccinated and monitored thereafter for their continuous health and well-being.The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and possibly to quickly eradicate this disease fully, along with the implementation of other preventive measures. In order to accomplish this feat more effectively, as many people as possible need to be vaccinated, especially for high-risk groups having co-morbid conditions such as diabetes, obesity and old age, and possibly those with various forms of immunodeficiencies, such as HIV/AIDS. This chapter focuses primarily on some of the basic biomedical aspects on vaccine design and use, and any possible concerns that need to be considered in getting people in the high-risk category vaccinated and monitored thereafter for their continuous health and well-being. |
| Author | Plummer, Maria M Pavia, Charles S |
| Author_xml | – sequence: 1 givenname: Charles S surname: Pavia fullname: Pavia, Charles S organization: Division of Infectious Diseases, New York Medical College, Valhalla, NY, United States – sequence: 2 givenname: Maria M surname: Plummer fullname: Plummer, Maria M organization: Department of Clinical Specialties, Division of Pathology, NYIT College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY, United States |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38620783$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVkEtLxDAUhYMozkP_gAvp0k1rXs1jMyDja2BgNuq2JG06E22S2rQD_nsLjjKuzoUD38c9M3DqgzcAXCGYIYjYrY6Zsy7DEKMMoQxCdAKmMBcwlTnip0f3BMxifIcQcyHxOZgQwTDkgkzBYrl5W92nSCZ7VZbWm5jUoUt2drtLOhs_EuWrxDo3-FAG13bB2WiqpFW9Nb6PF-CsVk00l4ecg9fHh5flc7rePK2Wd-u0RQL1KabQVJgwRHDFsCCSapNjjWhVaYkIUYZqYijNCce8IrpmNZJGM1VTbkpGyRwsfrjtoJ2pytHdqaZoO-tU91UEZYv_jbe7Yhv2heCSI5aPgJsDoAufg4l9MT5SmqZR3oQhFgQSKSDLx1Hm4PrY9Sf5HY18AyCEcYs |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 Elsevier Ltd. All rights reserved. Copyright © 2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd |
| Copyright_xml | – notice: Copyright © 2022 Elsevier Ltd. All rights reserved. – notice: Copyright © 2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd |
| DBID | NPM 7X8 5PM |
| DOI | 10.1016/bs.mim.2021.11.001 |
| DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 0580-9517 |
| EndPage | 279 |
| ExternalDocumentID | 38620783 |
| Genre | Journal Article |
| GroupedDBID | --K -~X .GJ 0R~ 123 8N9 8NA 8NF AAKMA AALRI AAXUO AAYSV ABGWT ABMAC ABQQC ACGFS ACXMD ADOJD ADVLN AENEX AFFNX AFOST AFTJW AGAMA AHMUE AKRWK ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF FDB HZ~ JDP MVM NEJ NPM O9- P2P SBF SDK SES SHL YNT YQT ZXP ~02 7X8 5PM |
| ID | FETCH-LOGICAL-p181t-240ed236132d628394be52b14ddb9133ae4b3e4453727d3bf6f19eb6af47ec643 |
| ISSN | 0580-9517 |
| IngestDate | Tue Sep 17 21:20:15 EDT 2024 Sat Oct 26 04:10:08 EDT 2024 Sat Nov 02 11:56:14 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 vaccines Obesity SARS-CoV-2 AIDS patients HIV Risk groups Diabetes Vaccines Immunocompromised patients |
| Language | English |
| License | Copyright © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p181t-240ed236132d628394be52b14ddb9133ae4b3e4453727d3bf6f19eb6af47ec643 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8797165 |
| PMID | 38620783 |
| PQID | 3039806578 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8797165 proquest_miscellaneous_3039806578 pubmed_primary_38620783 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-00-00 20220101 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – year: 2022 text: 2022-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Methods in microbiology |
| PublicationTitleAlternate | Methods Microbiol |
| PublicationYear | 2022 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0027892 |
| Score | 2.285238 |
| Snippet | The availability of multiple versions of vaccines designed to help prevent COVID-19 has offered an opportunity to at least control the current pandemic, and... |
| SourceID | pubmedcentral proquest pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | 269 |
| Title | COVID-19 vaccines for high risk and immunocompromised patients |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38620783 https://www.proquest.com/docview/3039806578 https://pubmed.ncbi.nlm.nih.gov/PMC8797165 |
| Volume | 50 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB5Sh5ZcQpO-nLZhC7kFmUi7klaXQkhbkgY3JSRtbkb7EPHBsomdQPvrO7O7spQ6hbYXYSR7JeYT629e3wDsmUqpSssqypKiikSibKRyjV4KV1paE0sZU4Pz8Et2fCk-X6VX7cxM112yUAP988G-kv9BFc8hrtQl-w_ILhfFE_gZ8cUjIozHv8L46OzbyYcoLvbvSk0JcqetsE8KxL5k3CUGqAFkSpXjN1PEFPllkFKdd3np0A2SdrWxk3GrzdQmmO58UW3IzrcB06-4uYUBLEN0u8sQXQ1xhKQbVEzlQYRMK-_uil4OttnW_DiVle3We_5qPpiMqas_iQekiOqjEx37zyYOAI7eE2UN27-eZUFgc-kRrDtFwx6sH56efz9tfWfp5lsvHzX0P1Gp3urtN-BJs-BDjsPv9a8dQnHxFDaDJ8AOPaxbsGbrbXjsZ4P-eAbvG3BZAy5DcBmBywhchuCyFXBZA-5zuPz08eLoOArDLqIZkqwFZbmsISUcnpgMOV8hlE0TFQtjVBFzXlqhuBUi5cg4DVdVVsWFVVlZidxq5JUvoFdPa_sKWKUPjDD480KmgmsaLJejcTQvY43-cNGHd41NRvhslCEqazu9nY-QzxSUac9lH156G41mXvVk1Fi0D_k96y2_QELl96_U42snWC5zEipLd_645mvYoFfSh7beQG9xc2vfItlbqN3wIvwC9yBT_Q |
| link.rule.ids | 230,314,780,784,885,4024,27923,27924,27925 |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19+vaccines+for+high+risk+and+immunocompromised+patients&rft.jtitle=Methods+in+microbiology&rft.au=Pavia%2C+Charles+S&rft.au=Plummer%2C+Maria+M&rft.date=2022&rft.issn=0580-9517&rft.volume=50&rft.spage=269&rft_id=info:doi/10.1016%2Fbs.mim.2021.11.001&rft_id=info%3Apmid%2F38620783&rft.externalDocID=38620783 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0580-9517&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0580-9517&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0580-9517&client=summon |